The Dilemma of New Drugs James MasonNick Freemantle Current Opinion 16 September 2012 Pages: 653 - 657
Common Errors and Controversies in Pharmacoeconomic Analyses Sarah ByfordStephen Palmer Leading Article 16 September 2012 Pages: 659 - 666
The Economic Burden of Migraine to Society Michel D. Ferrari Review Article 16 September 2012 Pages: 667 - 676
Socioeconomics of a Global Leprosy Eradication Programme Sharad S. NaikRamaswamy Ganapati Review Article 16 September 2012 Pages: 677 - 686
The Influence of Ill-Health Experience on the Valuation of Health Xavier BadiaMichael HerdmanPaul Kind Original Research Article 16 September 2012 Pages: 687 - 696
Modelling the Potential Economic Impact of Viral Load—Driven Triple Drug Combination Antiretroviral Therapy Aslam H. AnisRobert S. HoggMartin T. Schechter Original Research Article 16 September 2012 Pages: 697 - 705
MSQ: Migraine-Specific Quality-of-Life Questionnaire Priti JhingranSonia M. DavisRonald W. Helms Original Research Article 16 September 2012 Pages: 707 - 717
The Cost Effectiveness of Acamprosate in the Treatment of Alcoholism in Germany Peter K. SchädlichJosef Georg Brecht Original Research Article 16 September 2012 Pages: 719 - 730